This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Nanyang Technological University. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: The Innovative Contributions of Clement Yuen
Introduction
Clement Yuen is a notable inventor based in Singapore, recognized for his significant contributions to the field of medical diagnostics. His innovative approach to diagnosing malaria infection showcases the intersection of technology and healthcare.
Latest Patents
Clement Yuen holds a patent for a method of diagnosing malaria infection in a patient by Surface Enhanced Raman Spectroscopy (SERS). This method involves obtaining a sample from the patient and mixing it with a suspension of magnetic nanoparticles. These nanoparticles adsorb hemozoin present in the sample, allowing for the acquisition of SERS spectra. The correlation of these spectra to the presence or amount of hemozoin indicates the likelihood of malaria infection. This innovative technique has the potential to enhance the accuracy and efficiency of malaria diagnostics.
Career Highlights
Clement Yuen is affiliated with Nanyang Technological University, where he contributes to research and development in the field of medical technology. His work emphasizes the importance of integrating advanced scientific methods into practical applications that can improve patient outcomes.
Collaborations
Clement collaborates with his coworker, Quan Liu, to further explore and develop innovative solutions in medical diagnostics. Their combined expertise fosters a productive research environment that aims to address pressing health challenges.
Conclusion
Clement Yuen's work exemplifies the vital role of innovation in healthcare, particularly in the diagnosis of infectious diseases like malaria. His contributions not only advance scientific knowledge but also hold promise for improving public health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
